SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Novavax Q1 EPS $(0.580) Beats $(0.780) Estimate, Sales $3.377M Beat $1.740M Estimate

Novavax (NASDAQ:NVAX) reported quarterly losses of $(0.580) per share which beat the analyst consensus estimate of $(0.780) by 25.64 percent. This is a 427.27 percent decrease over losses of $(0.110) per share from the

Benzinga · 05/11/2020 20:05

Novavax (NASDAQ:NVAX) reported quarterly losses of $(0.580) per share which beat the analyst consensus estimate of $(0.780) by 25.64 percent. This is a 427.27 percent decrease over losses of $(0.110) per share from the same period last year. The company reported quarterly sales of $3.377 million which beat the analyst consensus estimate of $1.740 million by 94.08 percent. This is a 15.19 percent decrease over sales of $3.982 million the same period last year.